Coronary artery disease in giant cell arteritis: a systematic review and meta-analysis
Patompong Ungprasert1, Matthew J Koster1, Kenneth J Warrington1
1Division of Rheumatology, Department of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905.
Insights
Giant cell arteritis (GCA) is a chronic inflammatory condition. This meta-analysis found no statistically significant increased risk of coronary artery disease (CAD) in patients with GCA compared to controls.
Area of Science:
- Rheumatology
- Cardiology
- Epidemiology
Background:
- Giant cell arteritis (GCA) is a systemic vasculitis affecting large arteries.
- Chronic systemic inflammation is a known risk factor for cardiovascular diseases.
- The relationship between GCA and coronary artery disease (CAD) risk requires clarification.
Purpose of the Study:
- To systematically review and meta-analyze observational studies evaluating the association between GCA and the risk of developing CAD.
- To quantify the pooled risk of CAD in individuals diagnosed with GCA.
Main Methods:
- Systematic review and meta-analysis of observational studies.
- Inclusion of studies reporting relative risks, hazard ratios, or standardized incidence ratios for CAD in GCA patients versus controls.
- Calculation of pooled risk ratios and 95% confidence intervals using a random-effect model.
Main Results:
- Six studies comprising 10,868 GCA patients and 245,323 controls were analyzed.
- The pooled risk ratio for CAD in GCA patients was 1.51 (95% CI: 0.88-2.61), which was not statistically significant.
- High statistical heterogeneity (I² = 97%) was observed across the included studies.
Conclusions:
- This meta-analysis did not demonstrate a statistically significant increased risk of CAD in patients with GCA.
- Unlike other chronic inflammatory conditions, GCA may not confer a heightened risk for CAD.
- Further research may be warranted to explore potential confounding factors or specific subgroups.
Objective:
To investigate the association between giant cell arteritis (GCA) and risk of coronary artery disease (CAD).
Methods:
We conducted a systematic review and meta-analysis of observational studies that reported relative risks, hazard ratios, or standardized incidence ratios with 95% confidence interval comparing CAD risk in patients with GCA versus non-GCA controls. Pooled risk ratios and 95% confidence intervals were calculated using a random-effect, generic inverse variance of DerSimonian and Laird.
Result:
Six studies with 10,868 patients with GCA and 245,323 controls were identified and included in our data analysis. The pooled risk ratio of CAD in patients with GCA was 1.51 and did not achieve statistical significance (95% CI: 0.88-2.61). The statistical heterogeneity was high with an I(2) of 97%.
Conclusion:
In contrast to other chronic systemic inflammatory disorders, our meta-analysis did not show any statistically significant increased risk of CAD among patients with GCA.
More Related Videos
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
